Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001674324-26-000004
Filing Date
2026-05-06
Accepted
2026-05-06 16:51:21
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 15881
  Complete submission text file 0001674324-26-000004.txt   17674
Mailing Address 4 EMBARCADERO CENTER, SUITE 3110 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER, SUITE 3110 SAN FRANCISCO CA 94111 (415) 993-8565
5AM Ventures V, L.P. (Filed by) CIK: 0001674324 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Subject) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92742 | Film No.: 26949396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)